“The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients” (2026) Genetics and Molecular Research, 25(1), pp. 1–25. doi:10.4238/1fvw5h08.